Double-Blind Comparison of Absorbable Colloidal Bismuth Subcitrate and Nonabsorbable Bismuth Subnitrate in the Eradication of Helicobacter pylori and the Relief of Nonulcer Dyspepsia

Helicobacter

Volumn 5, Issue 3, 2000, Pages 169-175

  Whitehead, Mark W ^a   Phillips, Rosemary H ^a   Sieniawska, Christine E ^b   Delves, H Trevor ^b   Seed, Paul T ^c   Thompson, Richard P H ^a   Powell, Jonathan J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HELICOBACTER PYLORI;

ANTIINFECTIVE AGENT; ANTIULCER AGENT; BISMUTH; BISMUTH CITRATE; BISMUTH NITRATE; ORGANOMETALLIC COMPOUND;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DYSPEPSIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE ABSORPTION; MICROBIOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BISMUTH; DOUBLE-BLIND METHOD; DYSPEPSIA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL ABSORPTION; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; TREATMENT OUTCOME;

EID: 0034266552     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.2000.00027.x     Document Type: Article

References (32)

1. Bhasin DK, Sharma BC, Sinha SK, Ray P, Vaiphei K, Singh K. Helicobacter pylori eradication: Comparison of three treatment regimens in India. J Clin Gastroenterol 1999;28:348-51.
2. Gisbert JP, Parjares JM, Valle J. Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: A review. Helicobacter 1999;4:58-66.
3. Nie Y, Li Y, Wu H, Sha W, Du H, Dai S, Wang H, Li Q. Colloidal bismuth pectin: An alternative to bismuth subcitrate for the treatment of Helicobacter pylori-positive duodenal ulcer. Helicobacter 1999;4:128-34.
4. Choe YH, Kim SK, Son BK, Lee DH, Hong YC, Pai SH. Randomized placebo-controlled trial of Helicobacter pylori eradication for iron-deficiency anemia in preadolescent children and adolescents. Helicobacter 1999;4:135-9.
5. Gorbach SL. Bismuth therapy in gastrointestinal diseases. Gastroenterology 1990;99:863-75.
6. Marshall BJ, for ACG Committee on PDA-Related Matters. GI drug column: Use bismuth in gastroenterology. Am J Gastroenterol 1991;86:16-25.
7. Harris AW, Misiewicz JJ. Eradication of Helicobacter pylori. Bailliere's Clin Gastroenterol 1995; 9:583-613.
8. Van der Hulst RW, Keller JJ, Rauws EA, et al. Treatment of Helicobacter pylori infection: A review of the world literature. Helicobacter 1996; 1:6-19.
9. Tytgat GNJ, Axon ATR, Dixon MF, et al. Helicobacter pylori: Causal agent in peptic ulcer disease? World Congress in Gastroenterology Working Party Report. 1990:36-45.
10. Goodwin CS, Mendall MM, Northfield TC. Helicobacter pylori infection. Lancet 1997;349:265-9.
11. European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997;41:8-13.
12. Tillman LA, Drake FM, Dixon JS, et al. Review article: Safety of bismuth in the treatment of gastrointestinal diseases. Aliment Pharmacol Ther 1996; 10:459-67.
13. Nwokolo CU, Gavey CJ, Smith JTL, et al. The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate. Aliment Pharmacol Ther 1989;3:29-39.
14. Nwokolo CU, Mistry P, Pounder RE. The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate). Aliment Pharmacol Ther 1990;4:163-9.
15. Playford RJ, Matthews CH, Campbell MJ, et al. Bismuth induced encephalopathy caused by tri potassium dicitrato bismuthate in a patient with chronic renal failure. Gut 1990;31:359-60.
16. Gordon MF, Abrams RI, Rubin DB, Barr WB, Correa DD. Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus. Mov Disord 1995;10:220-2.
17. 2-receptor blockade on the bismuth absorption from three-ulcer healing compounds. Gastroenterology 1991;101:889-94.
18. Phillips RH, Whitehead MW, Delves HT, et al. Is quadruple 'therapy' safe? Gut 1997;41 (suppl 1):A89.
19. 13C-urea breath test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol 1991;3: 915-21.
20. Huber PJ. The behaviour of maximum likelihood estimates under non-standard conditions. In: Proceedings of the Fifth Berkeley Symposium in Mathematical Statistics and Probability. Berkeley, CA: University of California Press, 1967:221-33.
21. Lerang F, Moum B, Ragnhildstveit E, et al. Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: Experience from clinical practice in a population with a high frequency of metronidazole resistance. Am J Gastroenterol 1998;93:212-6.
22. de Boer WA. Bismuth triple therapy: Still a very important drug regimen for curing Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1999; 11:697-700.
23. de Boer W, Driessen W, Jansz A, et al. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995;345:817-20.
24. Talley NJ, Vakil N, Ballard ED, Fennerty MB. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med 1999;341:1106-111.
25. Talley NJ, Janssens J, Lauritsen K, István Rácz Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: Randomised double blind placebo controlled trial with 12 months' follow up. Br Med J 1999;318:833-7.
26. Blum AL, Talley NJ, O'Morain C, et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998;339:1875-81.
27. Goh KL, Paraaskthi N, Peh SC, Wong NW, Lo YL, Puthucheary SD. Helicobacter pylori infection and non-ulcer dyspepsia: The effect of treatment with colloidal bismuth subcitrate. Scand J Gastroenterol 1991;26:1123-31.
28. Sandha GS, Hunt RH, Veldhuyzen van Zanten SJ. A systematic overview of the use of diary cards, quality-of-life questionnaires, and psychometric tests in treatment trials of Helicobacter pylori-positive and -negative non-ulcer dyspepsia. Scand J Gastroenterol 1999;34:244-9.
29. Goddard AF, Logan RP, Lawes S, Spiller RC. Randomized controlled comparison of nitroimidazoles for the eradication of Helicobacter pylori and relief of ulcer-associated and non-ulcer dyspepsia. Aliment Pharmacol Ther 1999;13:637-42.
30. Hillemand P, Palliera M, Laquais B, et al. Traitement bismuthique et bismuthemie. Semin Hop Paris 1977;53:1663-9.
31. Kashifard M, Malekzadeh BSN, Siavoshi F, Mikaeli J, Massarrat S. Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy comprising omeprazole and amoxicillin. Eur J Gastroenterol Hepatol 1998;10:847-50.
32. Scarpignato C, Pelosini I. Bismuth compounds for eradication of Helicobacter pylori: Pharmacology and safety. Prog Basic Clin Pharmacol 1999;11: 87-127.